$3.47
-5.6%Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
Last Annual Value
6.73M
3-Year CAGR
-8%
5-Year CAGR
24%
10-Year CAGR
22%
| Company | Total Payables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Treace Medical Concepts, Inc. NASDAQ:TMCI | 6.73M | -17.2% | 10.6% | N/A | |
![]() RxSight, Inc. NASDAQ:RXST | 5.30M | 11.1% | 25.7% | N/A | |
![]() Bioventus Inc. NASDAQ:BVS | 16.06M | -16.7% | -8.5% | N/A | |
![]() Enhabit, Inc. NYSE:EHAB | 9.20M | -16.5% | -11.7% | N/A | |
![]() Delcath Systems, Inc. NASDAQ:DCTH | 2.66M | 38.0% | 33.0% | 16.2% | |
![]() Design Therapeutics, Inc. NASDAQ:DSGN | 2.31M | 6.0% | 7.4% | N/A | |
![]() NeuroPace, Inc. NASDAQ:NPCE | 2.22M | -1.7% | 10.0% | N/A | |
![]() Evolus, Inc. NASDAQ:EOLS | 23.36M | 76.2% | 15.4% | 23.3% | |
![]() Senseonics Holdings, Inc. NASDAQ:SENS | 4.06M | -3.9% | 27.5% | 2.8% | |
![]() Standard BioTools Inc. NASDAQ:LAB | 5.41M | -18.7% | -12.6% | 3.1% | |
![]() OrthoPediatrics Corp. NASDAQ:KIDS | 20.98M | -2.7% | 17.6% | 19.5% |
Continue your TMCI research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.